A Study of Dostarlimab vs Placebo After Chemoradiation in Adult Participants With Locally Advanced Unresected Head and Neck Squamous Cell Carcinoma
for Neoplasms, Head and Neck
Drug: Dostarlimab
36 locations incl. Jonesboro
Sponsor: GlaxoSmithKline
Sex: All·Age: 18+
Code: NCT06256588·Phase 3·Recruiting